Tina Raine‐Bennett

Kaiser Permanente — United States

Medicine · Health Sciences

35h-index3.8kcitations144works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cervical Cancer and HPV Research(48), Reproductive Health and Contraception(42), Maternal and Perinatal Health Interventions(23), Global Maternal and Child Health(17), Uterine Myomas and Treatments(17)

Publications141 total

Editorial Board
Contraception·2024Open Access
Editorial Board
Contraception·2024Open Access
The Effect of an Oxytocin Decision Support Checklist on Oxytocin Use and Maternal and Neonatal Outcomes: A Retrospective Cohort Study
American Journal of Perinatology·2024· 1 cited
Risks of Uterine Perforation and Expulsion Associated With Intrauterine Devices
Obstetrics and Gynecology·2023· 25 citedOpen Access
A novel human papillomavirus and host DNA methylation score and detection of cervical adenocarcinoma
JNCI Journal of the National Cancer Institute·2023· 7 citedOpen Access
The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma
Gynecologic Oncology·2023· 15 citedOpen Access
Fetal heart rate patterns and the incidence of adverse events after oral misoprostol administration for cervical ripening among low-risk pregnancies
The Journal of Maternal-Fetal & Neonatal Medicine·2023· 2 citedOpen Access
Demographic, Reproductive, and Medical Risk Factors for Intrauterine Device Expulsion
Obstetrical & Gynecological Survey·2023· 1 cited
Data from Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women
2023Open Access
Table S1 and S2 from Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women
2023Open Access
Table S1 and S2 from Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women
2023Open Access
Supplementary Tables 1-3 from The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test
2023Open Access
Data from The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test
2023Open Access
Data from Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women
2023Open Access
Data from The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test
2023Open Access
Supplementary Tables 1-3 from The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test
2023Open Access
Provider- and Facility-Level Variation in Precancerous Cervical Biopsy Diagnoses
Journal of Lower Genital Tract Disease·2023· 3 citedOpen Access
Demographic, Reproductive, and Medical Risk Factors for Intrauterine Device Expulsion
Obstetrics and Gynecology·2022· 17 citedOpen Access
Labor Induction Outcomes with Outpatient Misoprostol for Cervical Ripening among Low-Risk Women
American Journal of Perinatology·2022· 7 cited
Gaps in the screening process for women diagnosed with cervical cancer in four diverse <scp>US</scp> health care settings
Cancer Medicine·2022· 7 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Mark Schiffman(26), Philip E. Castle(24), Thomas Lorey(22), Nicolas Wentzensen(20), Julia C. Gage(19), Nancy Poitras(16), Li C. Cheung(14), Barbara Fetterman(14), Hormuzd A. Katki(13), Robert D. Burk(12), Brian Befano(11), Walter Kinney(10), Lisa Mirabello(8), Zigui Chen(8), Meredith Yeager(7), Kai Yu(7), Michael Cullen(7), Joseph F. Boland(7), Sara Bass(7), Mary Anne Armstrong(7)